HK Stock MarketDetailed Quotes

MP CARDIOFLOW-B (02160)

Watchlist

1.280
0.0000.00%

15min DelayMarket Closed Sep 7 09:20 CST

1.63BMarket Cap-11.13P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MP CARDIOFLOW-B (02160) Earnings Dates, Reports & Conference Call

02160 Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2027/FY	-- / 325.637M	--
--	2026/FY	-- / 300.125M	--
Mar 30, 2026	2025/FY	394.345M / 485.216M	--
Mar 27, 2025	2024/FY	361.565M / 454.030M	--
Mar 27, 2024	2023/FY	336.215M / 356.374M	--

DatePeriodRevenue/EstimateEarnings Call

--2027/FY-- / 325.637M--

--2026/FY-- / 300.125M--

Mar 30, 20262025/FY394.345M / 485.216M--

Mar 27, 20252024/FY361.565M / 454.030M--

Mar 27, 20242023/FY336.215M / 356.374M--

Unlock Free Earnings Estimates

Open Account

02160 Historical Earnings Dates & Reports

MP CARDIOFLOW-B: INSIDE INFORMATIONDELAY IN PUBLICATION OF THE INTERIM RESULTSFOR THE SIX MONTHS ENDED JUNE 30, 2026;POSTPONEMENT OF DATE OF BOARD MEETING;ANDSUSPENSION OF TRADING

Sep 1 08:56

MP CARDIOFLOW-B: POSTPONEMENT OF DATE OF BOARD MEETING

Aug 26 22:58

MP CARDIOFLOW-B: DATE OF BOARD MEETING

CardioFlow Medtech will convene a board meeting on August 26 to review its interim results and dividend.

Aug 14 18:42

MP CARDIOFLOW-B: RESULTS FORECAST FOR THE FIRST HALF OF 2026

Xintong Medical forecasts that its revenue for the first half of 2026 will be no less than USD 153 million, with a net loss not exceeding USD 25 million.

Aug 11 22:12